Syros Pharmaceuticals (NASDAQ:SYRS) reported its Q1 earnings results on Monday, May 16, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Syros Pharmaceuticals beat estimated earnings by 14.89%, reporting an EPS of $-0.4 versus an estimate of $-0.47.

Revenue was up $640.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.09 which was followed by a 0.9% drop in the share price the next day.

Here's a look at Syros Pharmaceuticals's past performance:

To track all earnings releases for Syros Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.